Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenues to be $1,111 million -$1,116 million against previous guidance of $1,094 million- $1,116 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | +0.32% |
|
-0.08% | -33.97% |
05-16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
05-09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.97% | 721M | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024